









Markets
/
Stocks
/
nasdaq-nbtx
/

Nanobiotix SA

NBTX

View Detailed Chart

6.800USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

322.35MMarket Cap

--P/E TTM



Nanobiotix SA

6.800

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

-3.72%

5 Days

-0.15%

1 Month

+39.63%

6 Months

+94.84%

Year to Date

+136.93%

1 Year

+29.77%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 7 analysts

STRONG BUY

Current Rating

8.200

Target Price

20.59%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Nanobiotix SA

NBTX

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(1)

Neutral(3)

Buy(8)

Indicators

Sell(1)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.223

Buy

RSI(14)

67.980

Neutral

STOCH(KDJ)(9,3,3)

79.655

Neutral

ATR(14)

0.418

High Vlolatility

CCI(14)

71.373

Neutral

Williams %R

20.763

Buy

TRIX(12,20)

1.552

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

6.796

Buy

MA10

6.329

Buy

MA20

5.775

Buy

MA50

4.929

Buy

MA100

4.178

Buy

MA200

3.912

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.

Ticker SymbolNBTX

CompanyNanobiotix SA

CEODr. Laurent Levy, Ph.D.

Websitehttps://www.nanobiotix.com